4//SEC Filing
Ho Robert 4
Accession 0001209191-20-019430
CIK 0001404644other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 9:39 PM ET
Size
8.5 KB
Accession
0001209191-20-019430
Insider Transaction Report
Form 4
Ho Robert
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2020-03-16+75,000→ 75,000 totalExercise: $0.00→ Common Stock (75,000 underlying) - Award
Stock Option (Right to Buy)
2020-03-16+200,000→ 200,000 totalExercise: $6.44Exp: 2030-03-16→ Common Stock (200,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The RSUs will vest as to 1/3 of the total number of shares underlying the award on each of March 16, 2021, March 16, 2022 and March 16, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F3]The RSUs do not expire; these securities either vest and settle or are canceled prior to the vesting date.
- [F4]The option vests as to 1/4 of the total shares on March 16, 2021, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001806254
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 9:39 PM ET
- Size
- 8.5 KB